May 2017

home / publications / health-system-edition / may2017
Chronic Obstructive Pulmonary Disease in Hospitalized Patients: Managing Exacerbations

Chronic Obstructive Pulmonary Disease in Hospitalized Patients: Managing Exacerbations

Shannon Anthony, PharmD;David Fett, PharmD;Deepali Dixit, PharmD, BCPS
May 19th 2017
ArticleClinical Care Focus

Pain Management in End-Stage Renal Disease

Pain Management in End-Stage Renal Disease

Jeffrey Fudin, PharmD, Amelia Persico, MBA;Erica Wegrzyn, PharmD
May 18th 2017
ArticleViewpoints

Recently we have received an increasing number of requests for consults on patients undergoing hemodialysis (HD) or with end-stage renal disease (ESRD).

Penicillin Allergies and Cross-Reactivity With Other Beta-Lactams

Penicillin Allergies and Cross-Reactivity With Other Beta-Lactams

Khalid Eljaaly, PharmD, CAPPS, BCPS, MS;Ryan Stevens, PharmD, BCPS
May 17th 2017
ArticleClinical Care Focus

Patient-reported allergy to penicillin antibiotics is a common scenario during health care encounters, with an estimated population prevalence of roughly 8% to 12%.

Hepatitis C: Oral Direct-Acting Antivirals Are Standard of Care

Hepatitis C: Oral Direct-Acting Antivirals Are Standard of Care

Jennifer Andres, PharmD, BCPS
May 17th 2017
ArticleFormulary Drug Review

Chronic hepatitis C virus (HCV) infection, estimated to affect up to 4 million Americans, is a leading cause of end-stage liver disease, hepatocellular carcinoma, and liver transplant.

Skin Cancer Treatment and Prevention Recommendations

Skin Cancer Treatment and Prevention Recommendations

Jennifer Gershman, PharmD, CPh, PACS
May 17th 2017
ArticleOncology Focus

Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma are the 3 main types of skin cancer.

From APhA: Nanaz Amini, PharmD, RPh, MS, on Diagnosing, Assessing, and Treating Melanoma

From APhA: Nanaz Amini, PharmD, RPh, MS, on Diagnosing, Assessing, and Treating Melanoma

Melissa Lauro
May 17th 2017
ArticleViewpoints

In March, Pharmacy Times® interviewed Nanaz Amini, PharmD, RPh, MS, of the Angeles Clinic & Research Institute, regarding the diagnosis and treatment of melanoma, as well as T-VEC treatment and everything involved in its administration.

Site Logo

340B Audit: Building a Self-Audit Program

Halena Leah Marcelin, PHARMD, MS, BCPS;Grayson K. Peek, PharmD, MS, BCPS;Rusol Karralli, PharmD, MS
May 16th 2017
ArticleNews & Highlights

The 340B program launched in 1992 to “stretch scarce federal resources” in order for participating entities to increase accessibility to care (eg, medications, clinical services, etc) for patients.